210 related articles for article (PubMed ID: 18587166)
1. Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia.
Peet M
Isr J Psychiatry Relat Sci; 2008; 45(1):19-25. PubMed ID: 18587166
[TBL] [Abstract][Full Text] [Related]
2. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.
Assisi A; Banzi R; Buonocore C; Capasso F; Di Muzio V; Michelacci F; Renzo D; Tafuri G; Trotta F; Vitocolonna M; Garattini S
Int Clin Psychopharmacol; 2006 Nov; 21(6):319-36. PubMed ID: 17012979
[TBL] [Abstract][Full Text] [Related]
3. [The essential fatty acids omega-6 and omega-3: from their discovery to their use in therapy].
Caramia G
Minerva Pediatr; 2008 Apr; 60(2):219-33. PubMed ID: 18449139
[TBL] [Abstract][Full Text] [Related]
4. Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial.
Emsley R; Niehaus DJ; Oosthuizen PP; Koen L; Ascott-Evans B; Chiliza B; van Rensburg SJ; Smit RM
Psychiatry Res; 2008 Dec; 161(3):284-91. PubMed ID: 18962989
[TBL] [Abstract][Full Text] [Related]
5. A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia.
Akter K; Gallo DA; Martin SA; Myronyuk N; Roberts RT; Stercula K; Raffa RB
J Clin Pharm Ther; 2012 Apr; 37(2):132-9. PubMed ID: 21501206
[TBL] [Abstract][Full Text] [Related]
6. Omega 3 fatty acids and inborn errors of metabolism.
Gil-Campos M; Sanjurjo Crespo P
Br J Nutr; 2012 Jun; 107 Suppl 2():S129-36. PubMed ID: 22591887
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects.
Chen AT; Chibnall JT; Nasrallah HA
Ann Clin Psychiatry; 2015 Nov; 27(4):289-96. PubMed ID: 26554370
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.
Hsu MC; Huang YS; Ouyang WC
Lipids Health Dis; 2020 Jul; 19(1):159. PubMed ID: 32620164
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid facts, Part I. Essential fatty acids as treatment for depression, or food for mood?
Pawels EK; Volterrani D
Drug News Perspect; 2008 Oct; 21(8):446-51. PubMed ID: 19034351
[TBL] [Abstract][Full Text] [Related]
11. Nutrition and schizophrenia: beyond omega-3 fatty acids.
Peet M
Prostaglandins Leukot Essent Fatty Acids; 2004 Apr; 70(4):417-22. PubMed ID: 15041037
[TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated fatty acid consumption and concentration among South Indian women during pregnancy.
Dwarkanath P; Muthayya S; Thomas T; Vaz M; Parikh P; Mehra R; Kurpad AV
Asia Pac J Clin Nutr; 2009; 18(3):389-94. PubMed ID: 19786387
[TBL] [Abstract][Full Text] [Related]
13. The use of omega-3 fatty acids in mental illness.
Gören JL; Tewksbury AT
J Pharm Pract; 2011 Oct; 24(5):452-71. PubMed ID: 21940602
[TBL] [Abstract][Full Text] [Related]
14. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials.
Hoffman DR; Boettcher JA; Diersen-Schade DA
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):151-8. PubMed ID: 19505812
[TBL] [Abstract][Full Text] [Related]
15. Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials.
Goh KK; Chen CY; Chen CH; Lu ML
J Psychopharmacol; 2021 Mar; 35(3):221-235. PubMed ID: 33586517
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids in the treatment of psychiatric disorders.
Peet M; Stokes C
Drugs; 2005; 65(8):1051-9. PubMed ID: 15907142
[TBL] [Abstract][Full Text] [Related]
17. Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health?
Milte CM; Sinn N; Howe PR
Nutr Rev; 2009 Oct; 67(10):573-90. PubMed ID: 19785689
[TBL] [Abstract][Full Text] [Related]
18. Dispelling the myths about omega-3 fatty acids.
Sadovsky R; Collins N; Tighe AP; Safeer RS; Morris CM; Brunton SA
Postgrad Med; 2008 Jul; 120(2):92-100. PubMed ID: 18654074
[TBL] [Abstract][Full Text] [Related]
19. [Omega-3 fatty acids].
Huyghebaert C
J Pharm Belg; 2007; 62(4):102-14. PubMed ID: 18269137
[TBL] [Abstract][Full Text] [Related]
20. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans.
Brenna JT; Salem N; Sinclair AJ; Cunnane SC;
Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):85-91. PubMed ID: 19269799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
